Comprehensive Analysis Examines Liposomal NMN Delivery, Dosage Research Context, Third-Party Verification Standards, and What ...
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
CRISPR Therapeutics Reports Strong 90% Response Rate and Lupus Remission in Landmark Zugo-Cel Update
CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR Therapeutics released a comprehensive clinical update on zugocaptagene geleucel ...
Ok so first things first, according to medical consultant Dr Ifeoma Ejikeme, ingrown hairs occur when the hair curls back or ...
Artificial intelligence-supported cell imaging could help laboratories to set defensible quality thresholds for living ...
When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...
Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...
Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.
Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, including redosed ...
Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...
HOUSTON, Dec. 3, 2025 /PRNewswire/ -- Avance Biosciences today announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results